Log in
Enquire now

List of Aciex Therapeutics patents

List of Aciex Therapeutics patents
List of Harman patents
List of Ethypharm patents
List of Luminit LLC patents
List of companies in Hanne Capital's investment portfolio
List of Oxygen Accelerator Oct 2012 companies
Patents where
Current Assignee
Name
is
Aciex TherapeuticsAciex Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8685439 Method for the treatment and prevention of eyelid swelling

Patent 8685439 was granted and assigned to Aciex Therapeutics on April, 2014 by the United States Patent and Trademark Office.

Aciex Therapeutics
Aciex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8685439
April 1, 2014
‌
US Patent 9254286 Ophthalmic formulations of cetirizine and methods of use

Patent 9254286 was granted and assigned to Aciex Therapeutics on February, 2016 by the United States Patent and Trademark Office.

Aciex Therapeutics
Aciex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9254286
February 9, 2016
‌
US Patent 8765725 Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

Patent 8765725 was granted and assigned to Aciex Therapeutics on July, 2014 by the United States Patent and Trademark Office.

Aciex Therapeutics
Aciex Therapeutics
Aciex Therapeutics
Aciex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8765725
July 1, 2014
‌
US Patent 8829005 Ophthalmic formulations of cetirizine and methods of use

Patent 8829005 was granted and assigned to Aciex Therapeutics on September, 2014 by the United States Patent and Trademark Office.

Aciex Therapeutics
Aciex Therapeutics
Aciex Therapeutics
Aciex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8829005
September 9, 2014
‌
US Patent 8569273 Ophthalmic formulations of cetirizine and methods of use

Patent 8569273 was granted and assigned to Aciex Therapeutics on October, 2013 by the United States Patent and Trademark Office.

Aciex Therapeutics
Aciex Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8569273
October 29, 2013
5 results
0 selected
5 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us